Table 2.
Comparison of protein content in bronchoalveolar lavage fluid among control group, paraquat group and rapamycin treatment group at 1, 3, 5, and 7 days after intraperitoneal injection (μg/L, x̅ ± s)
| Group | 1 d | 3 d | 5 d | 7 d | F * | P * |
|---|---|---|---|---|---|---|
| Control group | 46.7 ± 8.19 | 51.88 ± 14.60 | 53.67 ± 9.72 | 47.76 ± 10.96 | 0.034 | 0.991 |
| PQ group | 144.61 ± 19.80a | 151.18 ± 39.24a | 154.71 ± 28.63a | 153.28 ± 33.26a | 0.053 | 0.984 |
| RAPA treatment group | 113.55 ± 12.68a,b | 124.02 ± 16.30a,b | 108.08 ± 17.03a,b | 106.19 ± 17.40a,b | 0.032 | 0.992 |
Control group, Sprague-Dawley rats were intraperitoneally injected with 1.25 ml/kg saline solution; PQ group, Sprague-Dawley rats were intraperitoneally injected with 15 ml/kg 2% paraquat solution; RAPA treatment group, paraquat-poisoned Sprague-Dawley rats were immediately intraperitoneally injected with 1.25 ml/kg saline solution containing 4 mg/kg rapamycin; 1 d, 3 d, 5 d, 7 d, 1, 3, 5, and 7 days after intraperitoneal injection;
compared with control group, P < 0.001;
compared with PQ group, P < 0.001;
compared at 4 different time points in the same group, P > 0.05.